Merck KGaA, headquartered in Darmstadt, Germany, is one of the world’s oldest chemical and pharmaceutical companies, tracing its origins back to 1668. Over its long history, the company has grown into a global science and technology leader, operating in more than 60 countries and employing over 58,000 people. Merck KGaA is publicly traded in Germany and its American depositary receipts trade on the OTCMKTS under the ticker MKGAF.
In its Life Science segment, Merck KGaA provides innovative tools, services and technologies that support research, development and production in the biopharmaceutical and biotechnology industries. Flagship brands such as MilliporeSigma offer critical reagents, laboratory filtration systems and process solutions that help researchers and manufacturers advance from early-stage discovery through to commercial-scale production.
The company’s Healthcare division focuses on prescription medicines in areas including oncology, immunology, neurology and fertility. Merck KGaA has developed therapies targeting multiple sclerosis, oncology immunotherapeutics and hormone treatments for reproductive health. It also invests in digital health initiatives and partnerships to enhance patient care and streamline clinical development processes.
In its Performance Materials arm, Merck KGaA delivers specialty chemicals and materials for high-tech applications, including liquid crystals for advanced displays, semiconductor deposition materials and photoresists. These technologies serve customers across electronics, automotive and information technology industries worldwide. Since May 2021, the company has been led by Chairwoman and CEO Belén Garijo, who oversees strategic growth and innovation initiatives across all business areas.
AI Generated. May Contain Errors.
